UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Androgen-glucocorticoid interactions in the era of novel prostate cancer therapy

Nature reviews. Urology, 2016-01, Vol.13 (1), p.47-60

2016

Volltextzugriff (PDF)

Incorporating VEGF-targeted therapy in advanced urothelial cancer

Therapeutic Advances in Medical Oncology, 2017-01, Vol.9 (1), p.33-45

2017

Volltextzugriff (PDF)

Role of Somatostatin Analogues in the Treatment of Neuroendocrine Tumors

Hematology/oncology clinics of North America, 2016-02, Vol.30 (1), p.163-177

2016

Volltextzugriff (PDF)

Second-Line Therapies in Metastatic Urothelial Carcinoma

Hematology/oncology clinics of North America, 2015-04, Vol.29 (2), p.341-359

2015

Volltextzugriff (PDF)

Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer

The New England journal of medicine, 2024-03, Vol.390 (10), p.875-888

2024

Volltextzugriff (PDF)

First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers

Journal of clinical oncology, 2019-04, Vol.37 (12), p.946-953

2019

Volltextzugriff (PDF)

Gender-specific differences in a patient population with obstructive sleep apnea-hypopnea syndrome

Gender medicine, 2007-12, Vol.4 (4), p.329-338

2007

Volltextzugriff (PDF)

Safety and Clinical Activity of Atezolizumab in Patients with Metastatic Castration-Resistant Prostate Cancer: A Phase I Study

Clinical cancer research, 2021-06, Vol.27 (12), p.3360-3369

2021

Volltextzugriff (PDF)

Study EV-103 Cohort H: Antitumor activity of neoadjuvant treatment with enfortumab vedotin monotherapy in patients with muscle-invasive bladder cancer who are cisplatin-ineligible

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.4582-4582

2022

Volltextzugriff (PDF)

Role of somatostatin analogues in the treatment of neuroendocrine tumors

Journal of the National Comprehensive Cancer Network, 2015-01, Vol.13 (1), p.109-117

2015

Volltextzugriff (PDF)

Study EV-103 Cohort H: Antitumor activity of neoadjuvant treatment with enfortumab vedotin monotherapy in patients (pts) with muscle invasive bladder cancer (MIBC) who are cisplatin-ineligible

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.435-435

2022

Volltextzugriff (PDF)

Current Standards in Treatment of Radioiodine Refractory Thyroid Cancer

Current Treatment Options in Oncology, 2016-06, Vol.17 (6), p.30-30, Article 30

2016

Volltextzugriff (PDF)

Exposure-Response and Subgroup Analyses to Support Body Weight-Based Dosing of Brentuximab Vedotin in Children and Young Adults with Newly Diagnosed High-risk Classical Hodgkin Lymphoma

Clinical cancer research, 2024-08, Vol.30 (15), p.3273-3281

2024

Volltextzugriff (PDF)

Treatment of acute lymphoblastic leukemia in adults

Critical reviews in oncology/hematology, 2012-01, Vol.81 (1), p.94-102

2012

Volltextzugriff (PDF)

Development and Optimization of a Bladder Cancer Algorithm Using SEER-Medicare Claims Data

JCO clinical cancer informatics, 2024-09, Vol.8 (8), p.e2400073

2024

Volltextzugriff (PDF)

Consolidative radiotherapy in metastatic urothelial cancer (MUC)

Journal of clinical oncology, 2016-01, Vol.34 (2_suppl), p.406-406

2016

Volltextzugriff (PDF)

Real-world practice patterns in veterans with metastatic castration-resistant prostate cancer

Urologic oncology, 2020-01, Vol.38 (1), p.1.e1-1.e10

2020

Volltextzugriff (PDF)

Abstract A055: Racial disparities in metastatic castrate-resistant prostate cancer (mCRPC): Evidence from the Veterans Health Administration (VHA)

Cancer research (Chicago, Ill.), 2018-08, Vol.78 (16_Supplement), p.A055-A055

2018

Volltextzugriff (PDF)

A phase III trial comparing atezolizumab with enzalutamide vs enzalutamide alone in patients with metastatic castration-resistant prostate cancer (mCRPC)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.TPS5090-TPS5090

2017

Volltextzugriff (PDF)

Improvement of Psoriasis During Sunitinib Therapy for Renal Cell Carcinoma

The American journal of the medical sciences, 2010-06, Vol.339 (6), p.580-581

2010

Volltextzugriff (PDF)

Gender differences in self-reported use, perceived efficacy, and interest in future use of nicotine-dependence treatments: A cross-sectional survey in adults at a tertiary care center for nicotine dependence

Gender medicine, 2009-07, Vol.6 (2), p.362-368

2009

Volltextzugriff (PDF)

Phase II Study of Pazopanib and Paclitaxel in Patients with Refractory Urothelial Cancer

Clinical genitourinary cancer, 2016-10, Vol.14 (5), p.432-437

2016

Volltextzugriff (PDF)

Abstract 6737: Exposure-response and age subgroup analyses to support body-weight (BW) dosing of brentuximab vedotin (BV) in newly diagnosed high-risk classical Hodgkin lymphoma (cHL) in children and young adults (aged 2-21 years [y]): A randomized children’s oncology group phase 3 trial (AHOD1331)

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.6737-6737

2023

Volltextzugriff (PDF)

A first-in-human, first-in-class phase I trial of the anti-CD47 antibody Hu5F9-G4 in patients with advanced cancers

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.3019-3019

2016

Volltextzugriff (PDF)

Phase II study of pazopanib with weekly paclitaxel in refractory urothelial cancer

Journal of clinical oncology, 2015-03, Vol.33 (7_suppl), p.294-294

2015

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(34)

Publikationsform

Sprache

Englisch
(42)

Erscheinungsjahr

n.n

Thema

Science & Technology
(26)
Life Sciences & Biomedicine
(25)
Humans
(17)
Oncology
(13)
Male
(11)
Female
(7)
Middle Aged
(7)
Adult
(6)
Aged
(6)
Chemotherapy
(5)
Treatment Outcome
(5)
Biological And Medical Sciences
(4)
General & Internal Medicine
(4)
Hematology
(4)
Hematology, Oncology And Palliative Medicine
(4)
Medical Sciences
(4)
Medicine, General & Internal
(4)
Aged, 80 And Over
(3)
Antineoplastic Agents - Therapeutic Use
(3)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Androgen-glucocorticoid interactions in the era of novel prostate cancer therapy

Incorporating VEGF-targeted therapy in advanced urothelial cancer

Role of Somatostatin Analogues in the Treatment of Neuroendocrine Tumors

Second-Line Therapies in Metastatic Urothelial Carcinoma

Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer

First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers

Gender-specific differences in a patient population with obstructive sleep apnea-hypopnea syndrome

Safety and Clinical Activity of Atezolizumab in Patients with Metastatic Castration-Resistant Prostate Cancer: A Phase I Study

Study EV-103 Cohort H: Antitumor activity of neoadjuvant treatment with enfortumab vedotin monotherapy in patients with muscle-invasive bladder cancer who are cisplatin-ineligible

Role of somatostatin analogues in the treatment of neuroendocrine tumors

Study EV-103 Cohort H: Antitumor activity of neoadjuvant treatment with enfortumab vedotin monotherapy in patients (pts) with muscle invasive bladder cancer (MIBC) who are cisplatin-ineligible

Current Standards in Treatment of Radioiodine Refractory Thyroid Cancer

Exposure-Response and Subgroup Analyses to Support Body Weight-Based Dosing of Brentuximab Vedotin in Children and Young Adults with Newly Diagnosed High-risk Classical Hodgkin Lymphoma

Treatment of acute lymphoblastic leukemia in adults

Development and Optimization of a Bladder Cancer Algorithm Using SEER-Medicare Claims Data

Consolidative radiotherapy in metastatic urothelial cancer (MUC)

Real-world practice patterns in veterans with metastatic castration-resistant prostate cancer

Abstract A055: Racial disparities in metastatic castrate-resistant prostate cancer (mCRPC): Evidence from the Veterans Health Administration (VHA)

A phase III trial comparing atezolizumab with enzalutamide vs enzalutamide alone in patients with metastatic castration-resistant prostate cancer (mCRPC)

Improvement of Psoriasis During Sunitinib Therapy for Renal Cell Carcinoma

Gender differences in self-reported use, perceived efficacy, and interest in future use of nicotine-dependence treatments: A cross-sectional survey in adults at a tertiary care center for nicotine dependence

Phase II Study of Pazopanib and Paclitaxel in Patients with Refractory Urothelial Cancer

A first-in-human, first-in-class phase I trial of the anti-CD47 antibody Hu5F9-G4 in patients with advanced cancers

Phase II study of pazopanib with weekly paclitaxel in refractory urothelial cancer

Suchergebnisse filtern